lansoprazole has been researched along with Gastritis, Atrophic in 13 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Gastritis, Atrophic: GASTRITIS with atrophy of the GASTRIC MUCOSA, the GASTRIC PARIETAL CELLS, and the mucosal glands leading to ACHLORHYDRIA. Atrophic gastritis usually progresses from chronic gastritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Body weight was measured and blood was collected before and 12 weeks after H." | 5.43 | Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. ( Inoue, H; Ito, M; Kasai, C; Moritani, I; Oya, Y; Shiraki, K; Sugimoto, K; Takase, K; Takei, Y; Tameda, M; Tanaka, J, 2016) |
| " The most common adverse events of headache, diarrhea, and nausea have been reported in fewer than 5% of patients treated with lansoprazole or omeprazole." | 4.80 | Safety profile of the proton-pump inhibitors. ( Reilly, JP, 1999) |
| "Body weight was measured and blood was collected before and 12 weeks after H." | 1.43 | Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. ( Inoue, H; Ito, M; Kasai, C; Moritani, I; Oya, Y; Shiraki, K; Sugimoto, K; Takase, K; Takei, Y; Tameda, M; Tanaka, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Kodama, M | 2 |
| Okimoto, T | 2 |
| Mizukami, K | 1 |
| Hirashita, Y | 1 |
| Wada, Y | 1 |
| Fukuda, M | 1 |
| Matsunari, O | 1 |
| Okamoto, K | 1 |
| Ogawa, R | 1 |
| Fukuda, K | 1 |
| Kudo, Y | 1 |
| Kawahara, Y | 1 |
| Murakami, K | 2 |
| Bardet, R | 1 |
| Moreno, JP | 1 |
| Rodriguez, T | 1 |
| Trémeau, AL | 1 |
| Hernandez, É | 1 |
| Bolot, AL | 1 |
| Kasai, C | 1 |
| Sugimoto, K | 1 |
| Moritani, I | 1 |
| Tanaka, J | 1 |
| Oya, Y | 1 |
| Inoue, H | 1 |
| Tameda, M | 1 |
| Shiraki, K | 1 |
| Ito, M | 1 |
| Takei, Y | 1 |
| Takase, K | 1 |
| Sato, R | 1 |
| Watanabe, K | 1 |
| Fujioka, T | 1 |
| Sugiyama, T | 1 |
| Tsuchida, M | 1 |
| Yokota, K | 1 |
| Shimodan, M | 1 |
| Asaka, M | 2 |
| Mitsunaga, A | 1 |
| Matsumoto, R | 1 |
| Hoshino, Y | 1 |
| Nakamura, S | 1 |
| Murata, Y | 1 |
| Oi, I | 1 |
| Hayashi, N | 1 |
| Kuipers, EJ | 1 |
| Klinkenberg-Knol, EC | 1 |
| Festen, HP | 1 |
| Meuwissen, SG | 1 |
| Saita, H | 1 |
| Murakami, M | 1 |
| Takahashi, Y | 1 |
| Sou, Y | 1 |
| Kaitani, K | 1 |
| Nishio, K | 1 |
| Kita, T | 1 |
| Reilly, JP | 1 |
| Weinstein, WM | 1 |
| Ohkusa, T | 1 |
| Fujiki, K | 1 |
| Takashimizu, I | 1 |
| Kumagai, J | 1 |
| Tanizawa, T | 1 |
| Eishi, Y | 1 |
| Yokoyama, T | 1 |
| Watanabe, M | 1 |
| Kokkola, A | 1 |
| Sipponen, P | 1 |
| Rautelin, H | 1 |
| Härkönen, M | 1 |
| Kosunen, TU | 1 |
| Haapiainen, R | 1 |
| Puolakkainen, P | 1 |
4 reviews available for lansoprazole and Gastritis, Atrophic
| Article | Year |
|---|---|
[Reflux esophagitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Esophagitis, Peptic; Gastritis, Atrophic; | 2002 |
[Guidelines in the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gas | 2003 |
Safety profile of the proton-pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Diarrhea; Drug Interactions; Gastric Muc | 1999 |
Proton pump inhibitors and H. pylori infection: why the concern?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Enzyme Inhibitors; Gastritis, Atrophic; | 1999 |
1 trial available for lansoprazole and Gastritis, Atrophic
| Article | Year |
|---|---|
Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Administration Sch | 1998 |
8 other studies available for lansoprazole and Gastritis, Atrophic
| Article | Year |
|---|---|
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; | 2021 |
[A resistant diarrhea].
Topics: Aged, 80 and over; Anti-Ulcer Agents; Antidepressive Agents; Antidiarrheals; Colitis; Comorbidity; D | 2016 |
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Body Mass Index; Body We | 2016 |
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithrom | 2011 |
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial | 2002 |
Lansoprazole, H. pylori, and atrophic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Enzyme Inhibitors; Gastritis, Atrophic; Helicobacter Infect | 1997 |
Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Biop | 2001 |
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Combinations | 2002 |